Terkko Navigator / Radiotherapy & Oncology

Impact of a fiducial marker based ART strategy on margins in postoperative IMRT of gynecological tumors

Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer

The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: A systematic review and meta-analysis

Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas

Mechanisms of radiation-induced endothelium damage: Emerging models and technologies

Electron dose rate and oxygen depletion protect zebrafish embryos from radiation damage

Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China

Development and validation of a contouring guideline for the taste bud bearing tongue mucosa

Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer

Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study

Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey

Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning

Three large trials on radiotherapy for early breast cancer: What did we learn?

Patterns of palliative radiotherapy fractionation for brain metastases patients in New South Wales, Australia

Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation

The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws

Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors

Detection of an asymptomatic Covid-19 patient on CBCT-imaging

Pelvic insufficiency fractures following carbon-ion radiotherapy for uterine carcinomas

p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models

Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking

Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer

Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning

Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma

Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: A retrospective study

Clinical oncology module for the ESTRO core curriculum

Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours

Pattern of failure in IDH mutated, low grade glioma after radiotherapy – Implications for margin reduction

Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements

The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review

Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma

COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2

Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network

Ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer – Have we identified all the risk factors?

Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy

Definitive radiotherapy for prostate cancer in Norway 2006–2015: Temporal trends, performance and survival

Effect of radiotherapy interruption due to COVID-19 outbreak

Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era

Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study

Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study

Identification of the mutation signature of the cancer genome caused by irradiation

Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials

A qualitative classification signature for post-surgery 5-fluorouracil-based adjuvant chemoradiotherapy in gastric cancer

Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)

Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe – Results from an international survey

Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control

Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results

Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer

In response to: “Intraoperative radiation therapy (IORT) for soft tissue sarcoma – ESTRO IORT task force/ACROP recommendations”